Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Malignant Lymphoma

Free Subscription 18.05.2026 1 Am J Clin Pathol 1 Am J Hematol 2 Am J Surg Pathol 3 Br J Haematol 1 Eur J Haematol 2 Haematologica 1 J Clin Oncol 1 J Natl Cancer Inst 1 Proc Natl Acad Sci U S A

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Clin Pathol

1. AMADOR C, Poveda JC, Mohammed I, Bouska A, et al
   Real-time diagnosis of adult T-cell leukemia/lymphoma using HBZ RNA in situ hybridization.
   Am J Clin Pathol. 2026;165:aqag030.
   PubMed         Abstract available
   
   

   
   Am J Hematol

2. LI C, Lei T, Xu X, Lu J, et al
   RCLARITY: A Prospective Phase II Study of Rituximab Combined With Lenalidomide and Chidamide (RLC) for the Treatment of Relapsed/Refractory Angioimmunoblastic T-Cell Lymphoma.
   Am J Hematol. 2026 May 12. doi: 10.1002/ajh.70366.
   PubMed         Abstract available
   
   

   
   Am J Surg Pathol

3. KURZ KS, Ondrejka SL, Collinge B, Slack GW, et al
   Challenges in Diagnosing High-grade B-cell Lymphoma, NOS: Poor Interobserver Agreement on Its Morphologic Definition-An LLMPP Study.
   Am J Surg Pathol. 2026 May 11. doi: 10.1097/PAS.0000000000002565.
   PubMed         Abstract available
   
   
4. DONZEL M, Trecourt A, Fontaine J, Julia E, et al
   Marginal Zone Lymphoma With T-Follicular Helper Hyperplasia: Paving the Way for New Concepts in Cellular Plasticity and Unveiling Histopathologic Pitfalls.
   Am J Surg Pathol. 2026 May 14. doi: 10.1097/PAS.0000000000002567.
   PubMed         Abstract available
   
   

   
   Br J Haematol

5. BASTOS-BOENTE M, Medina-Herrera A, Navarro-Bailon A, Ferrero S, et al
   Development and validation of a novel prognostic index for mantle cell lymphoma integrating TP53 mutations (MIPI53).
   Br J Haematol. 2026 May 14. doi: 10.1111/bjh.70535.
   PubMed         Abstract available
   
   
6. SIMONSEN MR, Jerm MB, Johannesen TB, Enerstvedt L, et al
   Population-based survival after mantle cell lymphoma in Norway and Denmark: Limited impact of earlier BTKi access.
   Br J Haematol. 2026 May 12. doi: 10.1111/bjh.70538.
   PubMed        
   
   
7. SERNA A, Navarro V, Abrisqueta P
   Response to 'Statistical considerations in the comparison of immunotherapy and chemotherapy for POD24 follicular lymphoma'.
   Br J Haematol. 2026 May 11. doi: 10.1111/bjh.70523.
   PubMed        
   
   

   
   Eur J Haematol

8. GOWDA K, Gupta M, Aguilar A, Cruz C, et al
   Survival After Diagnosis of Cardiovascular Disease in Survivors of Adolescent and Young Adult Lymphoma.
   Eur J Haematol. 2026 May 14. doi: 10.1111/ejh.70220.
   PubMed         Abstract available
   
   

   
   Haematologica

9. OSBORNE W, Haynes E, Wilson W, Ediriwickrema K, et al
   Glofitamab and epcoritamab for large B cell lymphoma: a real-world retrospective UK analysis of efficacy, tolerability, and impact of treatment sequencing.
   Haematologica. 2026 May 14. doi: 10.3324/haematol.2026.300569.
   PubMed         Abstract available
   
   
10. GADDIPATI P, Ayad A, Epstein-Peterson Z, Palomba ML, et al
    CD20 re-emergence in a patient with diffuse large b-cell lymphoma who experienced a CD20-negative relapse after glofitamab treatment.
    Haematologica. 2026 May 14. doi: 10.3324/haematol.2025.300182.
    PubMed         Abstract available
    
    

    
    J Clin Oncol

11. LEONARD JP, Trneny M, Zhang H, Nowakowski GS, et al
    Erratum: Lenalidomide Plus Rituximab for Relapsed/Refractory Indolent Non-Hodgkin Lymphoma: 5-Year Follow-Up and Subgroup Analyses From the Phase III AUGMENT Trial.
    J Clin Oncol. 2026 May 13:JCO2601085. doi: 10.1200/JCO-26-01085.
    PubMed        
    
    

    
    J Natl Cancer Inst

12. DOLATKHAH R, Onyije FM, Bouaoun L, Olsson A, et al
    Early life environmental exposures and birth characteristics and childhood lymphoma risk: a systematic review and meta-analysis.
    J Natl Cancer Inst. 2026 May 7:djag136. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

13. WHITE MC, Lange PT, Stewart J, Damania B, et al
    NEK2 drives pathogenesis, drug resistance, and LMP1 expression in EBV-positive non-Hodgkin lymphoma.
    Proc Natl Acad Sci U S A. 2026;123:e2535550123.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Malignant Lymphoma is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum